#ClinicalTrialsSoWhite: How Drug Makers Are Using COVID-19 To Improve Trial Diversity

Pandemic Highlights Trials’ Minority Underrepresentation

 
• By Alaric DeArment
  
Closed up finger on keyboard with word CLINICAL TRIALS
Clinical trial diversity is a longtime topic of discussion, but COVID-19 has highlighted its importance • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D